Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non-Small Cell Lung Cancer
[Cancer Research] Organoid model is sufficient to test the effect of SLC7A1 on the growth of non-small cell lung cancer in an environment close to human physiological conditions.